BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 17540549)

  • 1. Biphasic release of indomethacin from HPMC/pectin/calcium matrix tablet: I. Characterization and mechanistic study.
    Wu B; Chen Z; Wei X; Sun N; Lu Y; Wu W
    Eur J Pharm Biopharm; 2007 Nov; 67(3):707-14. PubMed ID: 17540549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biphasic release of indomethacin from HPMC/pectin/calcium matrix tablet: II. Influencing variables, stability and pharmacokinetics in dogs.
    Wu B; Deng D; Lu Y; Wu W
    Eur J Pharm Biopharm; 2008 May; 69(1):294-302. PubMed ID: 17988844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sigmoidal release of indomethacin from pectin matrix tablets: effect of in situ crosslinking by calcium cations.
    Wei X; Sun N; Wu B; Yin C; Wu W
    Int J Pharm; 2006 Aug; 318(1-2):132-8. PubMed ID: 16675173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An in situ crosslinked compression coat comprised of pectin and calcium chloride for colon-specific delivery of indomethacin.
    Wei X; Lu Y; Qi J; Wu B; Chen J; Xu H; Wu W
    Drug Deliv; 2015 May; 22(3):298-305. PubMed ID: 24471938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on pectins as potential hydrogel matrices for controlled-release drug delivery.
    Sungthongjeen S; Pitaksuteepong T; Somsiri A; Sriamornsak P
    Drug Dev Ind Pharm; 1999 Dec; 25(12):1271-6. PubMed ID: 10612023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colonic delivery of compression coated nisin tablets using pectin/HPMC polymer mixture.
    Ugurlu T; Turkoglu M; Gurer US; Akarsu BG
    Eur J Pharm Biopharm; 2007 Aug; 67(1):202-10. PubMed ID: 17337171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of degree of esterification of pectin and calcium amount on drug release from pectin-based matrix tablets.
    Sungthongjeen S; Sriamornsak P; Pitaksuteepong T; Somsiri A; Puttipipatkhachorn S
    AAPS PharmSciTech; 2004 Feb; 5(1):E9. PubMed ID: 15198530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and evaluation of pectin-based colon-specific pulsatile capsule in vitro and in vivo.
    Liu J; Zhang L; Jia Y; Hu W; Zhang J; Jiang H
    Arch Pharm Res; 2012 Nov; 35(11):1927-34. PubMed ID: 23212634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naproxen release from sustained release matrix system and effect of cellulose derivatives.
    Sarfraz MK; Rehman NU; Mohsin S
    Pak J Pharm Sci; 2006 Jul; 19(3):251-5. PubMed ID: 16935834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of khaya gum as a directly compressible matrix system for controlled release.
    Odeku OA; Fell JT
    J Pharm Pharmacol; 2004 Nov; 56(11):1365-70. PubMed ID: 15525442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of a binary polymer system in drug release rate modulation. 1. Characterization of release mechanism.
    Kim H; Fassihi R
    J Pharm Sci; 1997 Mar; 86(3):316-22. PubMed ID: 9050799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. STUDYING THE IMPACT OF FORMULATION AND PROCESSING PARAMETERS ON THE RELEASE CHARACTERISTICS FROM HYDROXYPROPYL METHYLCELLULOSE MATRIX TABLETS OF DICLOFENAC.
    Elzayat EM; Abdel-Rahman AA; Ahmed SM; Alanazi FK; Habib WA; Sakr A
    Acta Pol Pharm; 2016; 73(2):439-52. PubMed ID: 27180437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction between fed gastric media (Ensure Plus®) and different hypromellose based caffeine controlled release tablets: comparison and mechanistic study of caffeine release in fed and fasted media versus water using the USP dissolution apparatus 3.
    Franek F; Holm P; Larsen F; Steffansen B
    Int J Pharm; 2014 Jan; 461(1-2):419-26. PubMed ID: 24342711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure and hydration properties of hydroxypropyl methylcellulose matrices containing naproxen and naproxen sodium.
    Katzhendler I; Mäder K; Friedman M
    Int J Pharm; 2000 May; 200(2):161-79. PubMed ID: 10867246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and evaluation of matrix-based controlled release tablets of diclofenac sodium and chondroitin sulphate.
    Avachat A; Kotwal V
    AAPS PharmSciTech; 2007 Oct; 8(4):E88. PubMed ID: 18181548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Swelling and erosion of pectin matrix tablets and their impact on drug release behavior.
    Sriamornsak P; Thirawong N; Weerapol Y; Nunthanid J; Sungthongjeen S
    Eur J Pharm Biopharm; 2007 Aug; 67(1):211-9. PubMed ID: 17267193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rheological characterization of xanthan gum and hydroxypropylmethyl cellulose with respect to controlled-release drug delivery.
    Talukdar MM; Vinckier I; Moldenaers P; Kinget R
    J Pharm Sci; 1996 May; 85(5):537-40. PubMed ID: 8742947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen.
    Cao QR; Choi YW; Cui JH; Lee BJ
    J Control Release; 2005 Nov; 108(2-3):351-61. PubMed ID: 16154656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of formulation change on drug release kinetics from hydroxypropylmethylcellulose matrix tablets.
    Xu G; Sunada H
    Chem Pharm Bull (Tokyo); 1995 Mar; 43(3):483-7. PubMed ID: 7774032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of drug release kinetics from ibuprofen matrix tablets using HPMC.
    Shoaib MH; Tazeen J; Merchant HA; Yousuf RI
    Pak J Pharm Sci; 2006 Apr; 19(2):119-24. PubMed ID: 16751122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.